Gastroesophageal reflux disease is very common chronic disease that consists of heartburn, regurgitation, stomach pain, or nausea. This study is aimed at clearing up these symptoms.
- Experiencing GERD symptoms (heartburn and regurgitation) 4 or more days a week
- Taking a Proton Pump Inhibitor (PPI) such as Omeprazole, Prevacid, Protonix, or others once daily
- Still experiencing breakthrough GERD symptoms despite taking PPI
Participants in this study will receive all study related medical care, examinations, and potential endoscopies (EGD) at no cost to them or their insurance.
If you would like to hear more about this trial, or see if you qualify to participate, please contact us at 801.409.2040. You can also reach us via e-mail or by submitting the form to your right.